1. The Development of the Romanian Scorecard HTA System
Ciprian-Paul Radu, MD, PhD, Nona Delia Chiriac, MD, PhD, Alexandra Mihaela Pravat, MSc 
Value in Health Regional Issues 
Volume 10, Pages (September 2016)
DOI: /j.vhri
Copyright © 2016 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Main stakeholders involved in the Romanian scorecard HTA system from HTA, health technology assessment; MAH, market authorization holder; NDA, National Drugs Agency.
Value in Health Regional Issues  , 41-47DOI: ( /j.vhri )
Copyright © 2016 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

3. Fig. 2
Number of new drugs with unconditional reimbursement by therapeutic area, November 2014 list update.
Value in Health Regional Issues  , 41-47DOI: ( /j.vhri )
Copyright © 2016 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions